The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic predictors of brain metastases in breast cancer.
 
Anton Safonov
No Relationships to Disclose
 
Deborah Smith
No Relationships to Disclose
 
Subhiksha Nandakumar
No Relationships to Disclose
 
Emanuela Ferraro
No Relationships to Disclose
 
Junchao Shen
No Relationships to Disclose
 
Ishaani Khatri
No Relationships to Disclose
 
Rahul Kumar
No Relationships to Disclose
 
Julia An
No Relationships to Disclose
 
Justin Jee
Patents, Royalties, Other Intellectual Property - MDSeq, Inc
 
Mark Robson
Consulting or Advisory Role - OptumHealth
Research Funding - Artios (Inst); AstraZeneca (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - Clinical Care Options; Clinical Education Alliance; MJH Healthcare Holdings, LLC; MyMedEd; Pfizer; Physicans' Education Resource; Research to Practice
(OPTIONAL) Uncompensated Relationships - Artios; Foundation Medicine; GlaxoSmithKline; Merck; Pfizer; Tempus; Zenith Pharmaceuticals
 
Adrienne Boire
Consulting or Advisory Role - Apellis Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Boire A and J Massagué, inventors. Sloan Kettering Institute, assignee. Modulating Permeability Of The Blood Cerebrospinal Fluid Barrier. United States Provisional Application No.: 62/258,044. November 20, 2015. (Inst); Boire A, Chen Q and J Massagué, inventors. Sloan Kettering Institute, assignee. Methods for Treating Brain Metastasis. United States 10413522, awarded September 17, 2019. (Inst); Boire A, inventor. Sloan Kettering Institute, assignee. Methods of Treating Leptomeningeal Metastasis. United States Provisional Application No.: 63/052,139. Jul 15, 2020 (Inst)
(OPTIONAL) Uncompensated Relationships - Evren Technologies
 
Nikolaus Schultz
Honoraria - OneOncology
 
Nelson Moss
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); GT Medical Technologies (Inst)
 
Walid Chatila
No Relationships to Disclose
 
Luke Pike
Employment - Memorial Sloan-Kettering Cancer Center
Stock and Other Ownership Interests - Clovis Oncology; Novavax; Schrodinger
Consulting or Advisory Role - Aviko; Dxcover; Genece Health; Monograph Capital; Turnstone Bio
Research Funding - Caris Life Sciences; Delfi Diagnostics; Genece Health; Harbinger Health
 
Pedram Razavi
Honoraria - Daiichi Sankyo/Astra Zeneca; Pfizer
Consulting or Advisory Role - AstraZeneca; bioTheranostics; Epic Sciences; Guardant Health; Loxo/Lilly; Myriad Genetics; NeoGenomics Laboratories; Novartis; PAIGE.AI; Prelude Therapeutics; SAGA Diagnostics; Tempus
Research Funding - AstraZeneca (Inst); Biovica (Inst); Epic Sciences (Inst); GRAIL (Inst); Guardant Health (Inst); Hologic/Biotheranostics (Inst); Illumina (Inst); Invitae (Inst); Myriad Genetics (Inst); NeoGenomics Laboratories (Inst); Novartis (Inst); Tempus (Inst)